Stage IV Cervical Cancer FIGO 2018
2 clinical trials · Condition
◉ Watch Stage IV Cervical Cancer FIGO 2018
| Record | Firm | Date |
|---|---|---|
| Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer (NCT05021237) | University of Texas Southwestern Medical Center | 2022-02-01 |
| Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer (NCT04574635) | Mayo Clinic | 2020-11-17 |
Track Stage IV Cervical Cancer FIGO 2018 automatically
Every clearance here is in the API, with alerts when new ones post.